JRK's DCO-D tablets are designed to manage diabetes and prevent related co-morbidities by enhancing glucose utilization and metabolism. Unlike traditional anti-diabetic medications, these tablets regulate blood glucose levels while also safeguarding organ health and mitigating complications. Clinical trials indicate their efficacy and safety, making them a viable option for long-term use under medical supervision.

1. Diabetes tablets |JRK's D-CO-D Tablets
Diabetesisametabolicdisease occursdue tolackof insulinproductionordue to insulinresistance.
Basedon the insulinproductionandresistance there are twotypesof diabetes –type – 1 insulin
dependentandtype-2non-insulindependent.Eventhough the conditionlookssimple itcontain
variousunderlyingproblemswhichoccurovera periodof time calledco-morbidites.There are
variousdiabetestabletsandparenteral insulinavailablebutstill the conditionisnotcontrollableand
alsoleadsto co-morbidities.
There are manyanti-diabetestabletswhichare knowntocontrol the bloodglucose butstill the
patientswhoare on suchanti-diabetestabletsare alsoundergoingthe co-morbidites.
PresentingJRK’sDCODtabletsthatare indicatedtoprevent the co-morbiditiesdue todiabetes,to
protectthe variousorgans fromdamage and alsoregulatesthe bloodglucose levels.
JRK’sDCOD tablets,comesunderthe categoryof diabetestabletsare knowntoregulate the blood
glucose levels.The mechanismbywhichJRK’sDCODtabletsable topreventco-morbiditiesisthatit
increasesthe glucose utilizationandmetabolism.
Generally,manycomplicationsindiabetesare due topoor glucose utilizationof glucoseatcellular
level thatresultsinpoorcellularfunctioningwhichprogressivelyresultsindamage of cell ordis-
functioningof the cells.
JRK’sDCOD tabletsmakescellstoincrease the utilizationof glucose andhence preventstheseco-
morbidities.JRK’sDCODtabletsunlike regularanti-diabetestablets, itworksonbothglucose
regulationandpreventionof co-morbidities.JRK’sDCODtabletsproventoprotectorganhealth.
JRK’sDCOD tabletsare proventopreventthe proteinuriaconditionsbyregulatingthe creatineand
creatinine levelsandthere bypreventthe burdenonkidneyandprotectsfromdamage.
Clinical trialsonJRK’sDCODtabletsalongwithanti-diabetestabletsalsoprove thatthe co-
prescriptionincreasesthe glucose regulationandalsopreventsthe pseudohunger.
JRK’sDCOD tabletsare provenforitssafetyat invitrolevel onvariouscell linessuchaskidneycells,
nerve cells,muscle cells,hepaticcellsandpancreaticcells.Therefore,one cantake confidentlywith
the advice of doctor for longerduration.
JRK’sDCOD tabletsusage onregularbasispreventsco-morbiditiesandalsoregulatesthe blood
glucose andimprovesthe wellbeingof the diabeticpatient.